Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs IND SWIFT LA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VAISHALI PHARMA IND SWIFT LA VAISHALI PHARMA /
IND SWIFT LA
 
P/E (TTM) x 25.7 13.0 198.2% View Chart
P/BV x 4.6 0.9 534.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VAISHALI PHARMA    IND SWIFT LA
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
IND SWIFT LA
Mar-23
VAISHALI PHARMA /
IND SWIFT LA
5-Yr Chart
Click to enlarge
High Rs19477 251.6%   
Low Rs6451 125.9%   
Sales per share (Unadj.) Rs66.0204.3 32.3%  
Earnings per share (Unadj.) Rs6.38.1 77.3%  
Cash flow per share (Unadj.) Rs6.717.8 37.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.3115.4 27.1%  
Shares outstanding (eoy) m10.5559.09 17.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.00.3 623.2%   
Avg P/E ratio x20.67.9 260.5%  
P/CF ratio (eoy) x19.13.6 532.2%  
Price / Book Value ratio x4.10.6 743.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,3613,785 36.0%   
No. of employees `000NANA-   
Total wages/salary Rs m131,262 1.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m69712,073 5.8%  
Other income Rs m22335 6.7%   
Total revenues Rs m71912,408 5.8%   
Gross profit Rs m942,026 4.6%  
Depreciation Rs m5574 0.9%   
Interest Rs m23922 2.4%   
Profit before tax Rs m88865 10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m22387 5.8%   
Profit after tax Rs m66478 13.8%  
Gross profit margin %13.516.8 80.2%  
Effective tax rate %25.444.7 56.7%   
Net profit margin %9.54.0 239.3%  
BALANCE SHEET DATA
Current assets Rs m72711,631 6.2%   
Current liabilities Rs m3213,711 8.6%   
Net working cap to sales %58.365.6 88.8%  
Current ratio x2.33.1 72.3%  
Inventory Days Days1810 172.2%  
Debtors Days Days2,8091,528 183.9%  
Net fixed assets Rs m616,297 1.0%   
Share capital Rs m105598 17.6%   
"Free" reserves Rs m2246,221 3.6%   
Net worth Rs m3306,819 4.8%   
Long term debt Rs m527,526 0.7%   
Total assets Rs m78817,942 4.4%  
Interest coverage x4.91.9 253.8%   
Debt to equity ratio x0.21.1 14.4%  
Sales to assets ratio x0.90.7 131.5%   
Return on assets %11.27.8 144.2%  
Return on equity %20.07.0 285.5%  
Return on capital %29.112.5 233.3%  
Exports to sales %25.273.4 34.3%   
Imports to sales %7.80-   
Exports (fob) Rs m1768,859 2.0%   
Imports (cif) Rs m54NA-   
Fx inflow Rs m1768,859 2.0%   
Fx outflow Rs m55285 19.3%   
Net fx Rs m1218,574 1.4%   
CASH FLOW
From Operations Rs m111,946 0.6%  
From Investments Rs m3-134 -2.1%  
From Financial Activity Rs m-17-1,857 0.9%  
Net Cashflow Rs m-4-44 8.4%  

Share Holding

Indian Promoters % 26.6 42.0 63.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 19.0 -  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.4 58.0 126.5%  
Shareholders   9,181 24,633 37.3%  
Pledged promoter(s) holding % 0.0 86.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VAISHALI PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VAISHALI PHARMA vs IND SWIFT LA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VAISHALI PHARMA vs IND SWIFT LA Share Price Performance

Period VAISHALI PHARMA IND SWIFT LA
1-Day -4.34% 2.56%
1-Month -4.79% -7.66%
1-Year -3.51% 81.37%
3-Year CAGR 62.23% 10.40%
5-Year CAGR 39.78% 19.70%

* Compound Annual Growth Rate

Here are more details on the VAISHALI PHARMA share price and the IND SWIFT LA share price.

Moving on to shareholding structures...

The promoters of VAISHALI PHARMA hold a 26.6% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VAISHALI PHARMA and the shareholding pattern of IND SWIFT LA.

Finally, a word on dividends...

In the most recent financial year, VAISHALI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of VAISHALI PHARMA , and the dividend history of IND SWIFT LA.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.